Pyridine

Pyridine

SCHEMBL5452272

O=C(Cl)Oc1ccccc1.c1ccncc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.51
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 6/20 0.42
LMNA P02545 2/20 0.42
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ALOX15 P16050 2/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP1A2 P05177 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL28471241 0.87 TDP1 (0.47) HSD17B10ALDH1A1ATMTDP1L3MBTL1
Benzene SCHEMBL7925278 0.87 TDP1 (0.50) CYP19A1HSD17B10ALDH1A1ATMTDP1
SCHEMBL3302 0.87 TDP1 (0.50) CYP19A1HSD17B10ALDH1A1ATMTDP1
SCHEMBL370622 0.87 TDP1 (0.50) CYP19A1HSD17B10ALDH1A1ATMTDP1
SCHEMBL27588343 0.85 TDP1 (0.45) CYP19A1HSD17B10ALDH1A1ATMTDP1
SCHEMBL10975650 0.85 TDP1 (0.48) CYP19A1HSD17B10ALDH1A1ATMTDP1
Bicarbonate SCHEMBL29032037 0.85 TDP1 (0.48) CYP19A1HSD17B10ALDH1A1ATMTDP1
SCHEMBL11224568 0.85 TDP1 (0.48) CYP19A1HSD17B10ALDH1A1ATMTDP1
SCHEMBL27326182 0.85 TDP1 (0.48) CYP19A1HSD17B10ALDH1A1ATMTDP1
Hydrochloric Acid SCHEMBL3896561 0.85 TDP1 (0.48) CYP19A1HSD17B10ALDH1A1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166599-B2 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-01-23 US disclosed
US-20050090486-A1 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-04-28 US disclosed
US-20030134838-A1 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134838-A1 Trisubstituted pyrimidines APP, PSEN1, BACE1 CYP19A1 2060/4885HSD17B10 4059/4885ALDH1A1 753/4885
US-20050090486-A1 Trisubstituted pyrimidines APP, BACE1, PSEN1 CYP19A1 2594/4885HSD17B10 4457/4885ALDH1A1 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.